APA (7th ed.) Citation

L, W., S, S., A, N., & C, A. (2026). Nanomedicines from the patient perspective - 30 years after PEGylated liposomal doxorubicin. Journal of controlled release : official journal of the Controlled Release Society, 396, 115038. https://doi.org/10.1016/j.jconrel.2026.115038

Chicago Style (17th ed.) Citation

L, Wang, Sehdev S, Nadeem A, and Allen C. "Nanomedicines from the Patient Perspective - 30 years After PEGylated Liposomal Doxorubicin." Journal of Controlled Release : Official Journal of the Controlled Release Society 396 (2026): 115038. https://doi.org/10.1016/j.jconrel.2026.115038.

MLA (9th ed.) Citation

L, Wang, et al. "Nanomedicines from the Patient Perspective - 30 years After PEGylated Liposomal Doxorubicin." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 396, 2026, p. 115038, https://doi.org/10.1016/j.jconrel.2026.115038.